- Home
- TYG vs FTRE Comparison
TYG vs FTRE Comparison
Compare TYG & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYG
- FTRE
- Stock Information
- Founded
- TYG 2003
- FTRE 1996
- Country
- TYG United States
- FTRE United States
- Employees
- TYG N/A
- FTRE N/A
- Industry
- TYG Investment Managers
- FTRE Medical Specialities
- Sector
- TYG Finance
- FTRE Health Care
- Exchange
- TYG Nasdaq
- FTRE Nasdaq
- Market Cap
- TYG 728.7M
- FTRE 864.4M
- IPO Year
- TYG N/A
- FTRE N/A
- Fundamental
- Price
- TYG $43.73
- FTRE $10.19
- Analyst Decision
- TYG
- FTRE Hold
- Analyst Count
- TYG 0
- FTRE 9
- Target Price
- TYG N/A
- FTRE $12.81
- AVG Volume (30 Days)
- TYG 56.0K
- FTRE 1.4M
- Earning Date
- TYG 01-01-0001
- FTRE 11-07-2025
- Dividend Yield
- TYG 10.01%
- FTRE N/A
- EPS Growth
- TYG N/A
- FTRE N/A
- EPS
- TYG 5.19
- FTRE N/A
- Revenue
- TYG $18,090,640.00
- FTRE $2,733,500,000.00
- Revenue This Year
- TYG N/A
- FTRE N/A
- Revenue Next Year
- TYG N/A
- FTRE N/A
- P/E Ratio
- TYG $8.38
- FTRE N/A
- Revenue Growth
- TYG 32.84
- FTRE N/A
- 52 Week Low
- TYG $33.73
- FTRE $3.97
- 52 Week High
- TYG $48.76
- FTRE $25.28
- Technical
- Relative Strength Index (RSI)
- TYG 63.04
- FTRE 61.11
- Support Level
- TYG $42.85
- FTRE $9.26
- Resistance Level
- TYG $43.43
- FTRE $9.89
- Average True Range (ATR)
- TYG 0.38
- FTRE 0.55
- MACD
- TYG 0.11
- FTRE -0.01
- Stochastic Oscillator
- TYG 89.41
- FTRE 100.00
About TYG Tortoise Energy Infrastructure Corporation
Tortoise Energy Infrastructure Corp seeks to provide a high level of current income to stockholders. It invests in fixed-income and dividend-paying equity securities of power and energy infrastructure companies that provide stable and defensive characteristics throughout economic cycles.
About FTRE Fortrea Holdings Inc.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.